12 May 2025 - Erdafitinib is recommended as an option for the treatment of adults with unresectable or metastatic urothelial cancer ...
9 May 2025 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
8 May 2025 - Osimertinib mesylate, when used in combination with pemetrexed disodium heptahydrate and platinum-based chemotherapy, is recommended as an ...
7 May 2025 - Brentuximab vedotin, when used in combination with doxorubicin hydrochloride, dacarbazine and vinblastine sulphate is recommended as an ...
6 May 2025 - NICE is unable to make a recommendation on the use of omaveloxolone (Skyclarys) for the treatment of ...
1 May 2025 - Our final draft guidance recommends linzagolix (Yselty, Theramex) with hormonal add-back therapy for adults of reproductive age ...
24 April 2025 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
22 April 2025 - Real-world evidence is increasingly used and accepted by health technology assessment (HTA) bodies as supportive evidence ...
11 April 2025 - We've published final draft guidance recommending capivasertib with fulvestrant, which means the treatment will be funded immediately ...
10 April 2025 - Today, for the first time, we have given the green light to a targeted treatment for the ...
9 April 2025 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
31 March 2025 - The aim of this policy article is twofold: (i) to provide a summary and update of recent ...
2 April 2025 - NICE has published final evidence-based recommendations on the use of efanesoctocog alfa (Altuvoct) for the treatment ...
24 March 2025 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...
27 March 2025 - The Department of Health and Social Care has asked NICE to produce guidance on the use ...